Trastuzumab emtansine plus atezolizumab versus trastuzumab emtansine plus placebo in previously treated, HER2-positive advanced breast cancer (KATE2): a phase 2, multicentre, randomised, double-blind trial.
暂无分享，去创建一个
Sung-Bae Kim | S. Loi | R. Salgado | F. Esteva | L. Emens | S. Im | C. Saura | M. Beresford | S. D. de Haas | M. De Laurentiis | A. Mani | M. Patre | J. Shah | Haiying Liu | C. Lambertini | Yifan Wang | M. de Laurentiis | S. de Haas | Jigna Shah